Prestige Consumer Healthcare (PBH) Other Non-Current Liabilities (2013 - 2025)

Prestige Consumer Healthcare's (PBH) quarterly Other Non-Current Liabilities came in at $5.7 million in Q4 2025, up 14.28% year-on-year from $5.0 million in Q4 2024, and up 6.84% quarter-over-quarter from $5.4 million in Q3 2025.

Prestige Consumer Healthcare (PBH) Other Non-Current Liabilities (2013 - 2025) Analysis & Trends

Prestige Consumer Healthcare's Other Non-Current Liabilities history runs 13 years deep, the most recent figure standing at $5.7 million for Q4 2025.

  • On a quarterly basis, Other Non-Current Liabilities rose 14.28% year-over-year to $5.7 million in Q4 2025; TTM through Dec 2025 was $5.7 million, a 14.28% increase from a year earlier, with the FY2025 full-year figure at $5.4 million, down 41.31% from the prior year.
  • Other Non-Current Liabilities grew to $5.7 million in Q4 2025 per PBH's latest filing, from $5.4 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $9.2 million in Q1 2024 and bottomed at $5.0 million in Q4 2024.
  • The 5-year median for Other Non-Current Liabilities is $8.3 million (2021), against an average of $7.4 million.
  • Across the five-year window, Other Non-Current Liabilities slumped 66.15% in 2021 and advanced 14.28% in 2025, its largest moves.
  • Year by year, Other Non-Current Liabilities stood at $8.4 million in 2021, then rose by 5.21% to $8.9 million in 2022, then rose by 0.53% to $8.9 million in 2023, then sank by 43.61% to $5.0 million in 2024, then grew by 14.28% to $5.7 million in 2025.
  • Per Business Quant, the three latest PBH Other Non-Current Liabilities figures stand at $5.7 million (Q4 2025), $5.4 million (Q3 2025), and $5.4 million (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Prestige Consumer Healthcare 2.34 Bn 2.28 Bn 157.37 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 5.75 Mn
Sep 30, 2025 5.38 Mn
Jun 30, 2025 5.41 Mn
Mar 31, 2025 5.39 Mn
Dec 31, 2024 5.03 Mn
Sep 30, 2024 5.12 Mn
Jun 30, 2024 5.14 Mn
Mar 31, 2024 9.19 Mn
Dec 31, 2023 8.92 Mn
Sep 30, 2023 8.90 Mn
Jun 30, 2023 8.18 Mn
Mar 31, 2023 8.17 Mn
Dec 31, 2022 8.87 Mn
Sep 30, 2022 8.88 Mn
Jun 30, 2022 8.92 Mn
Mar 31, 2022 7.48 Mn
Dec 31, 2021 8.43 Mn
Sep 30, 2021 8.49 Mn
Jun 30, 2021 8.56 Mn
Mar 31, 2021 8.61 Mn